Novonesis
400.60 DKK
+3.06 %
Less than 1K followers
NSIS B
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
+3.06 %
+3.41 %
-1.28 %
-15.15 %
-1.74 %
-2.98 %
-6.38 %
+17.58 %
+982.70 %
Novonesis is a biochemistry company. The company develops enzymes and various microorganisms for industrial use. The enzymes are a protein used in a number of different industries, mainly in the agricultural and food industries. Novonesis products are used in various foods and clothing and the company holds sales on a global level. Novonesis was founded in 1921 and is headquartered in Bagsværd, Denmark.
Read moreMarket cap
187.6B DKK
Turnover
312.2M DKK
Revenue
28.59B
EBIT %
13.07 %
P/E
80.17
Dividend yield-%
1.04 %
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
25.2
2026
Annual report '25
23.3
2026
General meeting '26
All
Research
Press releases
ShowingAll content types
HCA Morgenbørs 26/11 - Positive markeder på håb om rentesænkninger
Trading by management and close relations of management
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools





